Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

  • Unknown sort schema '{last_sort_schema}' ignored
1.

Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation.

Bayrami S, Esmaili Z, SeyedAlinaghi S, Jamali Moghadam SR, Bayrami S, Akbari Javar H, Rafiee Tehrani M, Dorkoosh FA.

Pharm Dev Technol. 2018 Mar 26:1-13. doi: 10.1080/10837450.2018.1452936. [Epub ahead of print]

PMID:
29557733
2.

John Cunningham virus large T antigen detection in brain biopsy of an HIV-infected patient with glioblastoma multiforme: more than a coincidental finding.

Dehghan Manshadi SA, SeyedAlinaghi S, Mousavi SA, Salehi MR, Asadollahi-Amin A, Keyvani H.

AIDS. 2018 Mar 27;32(6):830-833. doi: 10.1097/QAD.0000000000001759. No abstract available.

PMID:
29543656
3.

Effect Of 8-Week of Hospital-Based Resistance Training Program on TCD4+ Cell Count and Anthropometric Characteristic of HIV Patients in Tehran, Iran: A Randomized Controlled Trial.

Ghayomzadeh M, SeyedAlinaghi S, Shamsi MM, Rezaei S, Earnest CP, Akbarnejad S, Taj L, Mohraz M, Navalta JW, Ghasemi P, Voltarelli FA.

J Strength Cond Res. 2017 Dec 6. doi: 10.1519/JSC.0000000000002394. [Epub ahead of print]

PMID:
29219895
4.

Pseudomonas Aeruginosa Osteomyelitis of the Pubic Bone: a Case Report.

Golrokhy R, Jamali S, Samaei M, SeyedAlinaghi S.

Infect Disord Drug Targets. 2017 Jul 13. doi: 10.2174/1871526517666170713102631. [Epub ahead of print]

PMID:
28707596
5.

Prevalence and Associated Factors of HIV Infection among Male Prisoners in Tehran, Iran.

SeyedAlinaghi S, Farhoudi B, Mohraz M, Golsoorat Pahlaviani F, Hosseini M, Farnia M, Shahbazi M, Alasvand R, Tashakoriyan M.

Arch Iran Med. 2017 Jun;20(6):356-360. doi: 0172006/AIM.007.

6.

Revision and Implementation of "Clinical Guideline for Tuberculosis and HIV in Prisons", Great Tehran Prison, Iran.

Farhoudi B, SeyedAlinaghi S, Tabarsi P, Mohraz M, Golrokhy R, Farnia M, Shahbazi M, Alasvand R, Ebrahimi B, Esfehani J, Tashakoriyan M.

Infect Disord Drug Targets. 2018;18(1):72-80. doi: 10.2174/1871526517666170518093529.

PMID:
28521672
7.

Prevalence of HIV in a Prison of Tehran by Active Case Finding.

Seyedalinaghi SA, Farhoudi B, Mohraz M, Mohammadi Firouzeh M, Hosseini M, Kamali K.

Iran J Public Health. 2017 Mar;46(3):431-432. No abstract available.

8.

Impulsivity, Sensation Seeking, and Risk-Taking Behaviors among HIV-Positive and HIV-Negative Heroin Dependent Persons.

Paydary K, Mahin Torabi S, SeyedAlinaghi S, Noori M, Noroozi A, Ameri S, Ekhtiari H.

AIDS Res Treat. 2016;2016:5323256. doi: 10.1155/2016/5323256. Epub 2016 Mar 8.

9.

Demographic, Clinical and Laboratory Profiles of HIV Infected Patients Admitted into Imam Khomeini Hospital of Tehran, Iran.

Firouzeh MM, Moradbeigi M, SeyedAlinaghi SA, Khodaei S, Sadrpour P, Bayanolhagh S, Ahsani-Nasab S, Sadeghi L, Mohraz M.

Infect Disord Drug Targets. 2016;16(2):113-20.

PMID:
26715444
10.

Evaluation of the association between Addiction Severity Index and depression with adherence to anti-retroviral therapy among HIV infected patients.

Paydary K, Ekhtiari H, Noori M, Rad MV, Hajiabdolbaghi M, SeyedAlinaghi S.

Infect Disord Drug Targets. 2015;15(3):177-83.

PMID:
26411558
11.

Health Needs of People Living with HIV/AIDS: From the Perspective of Policy Makers, Physicians and Consultants, and People Living with HIV/AIDS.

Moradi G, Mohraz M, Gouya MM, Dejman M, Seyedalinaghi S, Khoshravesh S, Malekafzali Ardakani H.

Iran J Public Health. 2014 Oct;43(10):1424-35.

12.

Early initiation of antiretroviral treatment: Challenges in the Middle East and North Africa.

Sardashti S, Samaei M, Firouzeh MM, Mirshahvalad SA, Pahlaviani FG, SeyedAlinaghi S.

World J Virol. 2015 May 12;4(2):134-41. doi: 10.5501/wjv.v4.i2.134. Review.

13.

Addressing predictors of HIV related risk behaviors: demographic and psychosocial profile of Iranian patients.

Zandmomen Z, Sardashti S, Firouzeh MM, Aminabad FJ, Ghanbariragheb H, SeyedAlinaghi S, Mohraz M.

J Infect Public Health. 2014 Nov-Dec;7(6):472-80. doi: 10.1016/j.jiph.2014.07.014. Epub 2014 Aug 30.

14.

Antiretroviral drug resistance among antiretroviral-naïve and treatment experienced patients infected with HIV in Iran.

Baesi K, Ravanshad M, Ghanbarisafari M, Saberfar E, Seyedalinaghi S, Volk JE.

J Med Virol. 2014 Jul;86(7):1093-8. doi: 10.1002/jmv.23898. Epub 2014 Apr 17.

PMID:
24740443
15.

Mechanisms of anti-retroviral drug resistance: implications for novel drug discovery and development.

Emamzadeh-Fard S, Esmaeeli S, Arefi K, Moradbeigi M, Heidari B, Fard SE, Paydary K, Seyedalinaghi S.

Infect Disord Drug Targets. 2013 Oct;13(5):330-6. Review.

PMID:
24712673
16.

The effectiveness of discharge planning on the knowledge, clinical symptoms and hospitalisation frequency of persons with schizophrenia: a longitudinal study in two hospitals in Tehran, Iran.

Khaleghparast S, Ghanbari B, Kahani S, Malakouti K, SeyedAlinaghi S, Sudhinaraset M.

J Clin Nurs. 2014 Aug;23(15-16):2215-21. doi: 10.1111/jocn.12499. Epub 2013 Dec 12.

PMID:
24329909
17.

Prevalence of HIV infection and the correlates among homeless in Tehran, Iran.

Zadeh AO, SeyedAlinaghi S, Hassanzad FF, Hajizadeh M, Mohamadi S, Emamzadeh-Fard S, Paydary K, Hosseini M.

Asian Pac J Trop Biomed. 2014 Jan;4(1):65-8. doi: 10.1016/S2221-1691(14)60210-0.

18.

Post marketing surveillance on safety and efficacy of IMOD in Iranian patients with HIV/AIDS.

Mohraz M, Sedaghat A, SeyedAlinaghi S, Asheri H, Mohammaddoust S, Gharibdoost F, Khorshid HR, Farhadi M, Madani SH, Kamali K.

Infect Disord Drug Targets. 2013 Feb;13(1):71-4.

PMID:
23713668
19.

Prevalence survey of infection with Treponema pallidum among HIV-positive patients in Tehran.

Badie, Yavari Z, Esmaeeli S, Paydary K, Emamzadeh-Fard S, Seyedalinaghi S, Rasoulinejad M.

Asian Pac J Trop Biomed. 2013 Apr;3(4):334-6. doi: 10.1016/S2221-1691(13)60074-X.

20.

Adherence to anti-retroviral therapy and its determinants in HIV/AIDS patients: a review.

Emamzadeh-Fard S, Fard SE, SeyedAlinaghi S, Paydary K.

Infect Disord Drug Targets. 2012 Oct;12(5):346-56. Review.

PMID:
23017163

Supplemental Content

Loading ...
Support Center